Healthcare Services - Long-term Care and Specialized Medical Facilities
Strategic Profile
2024 consolidated revenue totalled €5,282 million with organic growth of 6.6%, confirming the relevance of the Group's diversified portfolio strategy. Clariane expects 2025 EBITDA growth of 6% to 9% supported by organic revenue growth of around 5%. The company is executing a restructuring plan to strengthen its financial position through strategic divestitures.
Cyborg Score Rationale
2025 EBITDA pre-IFRS 16 stands at €594 million with improved margins in H2 2025 and operating free cash flow of €267m up 46%. The company has stabilized operations and improved profitability after challenges, though debt levels remain elevated from prior acquisitions.
Top Insights
Average nursing home occupancy rate improved to 90.4% in Q1 2025
Clariane certified Top Employer 2025 at European level and in all six countries where it operates
Over 60% of the disposal programme completed or secured, raising approximately €100 million per quarter
Diversified geographic footprint reduces regulatory and market concentration risk
Named Competitors
Senior Care Operations — European healthcare facility operator
Elderly Care Services — Senior care and healthcare facilities
Long-term Care — Fragmented market with local operators
Recent Developments
(February 2026) Full-year 2025 results show 3.1% EBITDA growth and 46% increase in operating free cash flow
(June 2025) Completed sale of Petits-fils home care network to Crédit Agricole for balance sheet strengthening
(April 2025) Q1 2025 revenue growth of approximately 5% with improved operational momentum
(September 2024) Joined SBF 120 index and CAC SBT 1.5° index
Open the full interactive Clariane SE report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.